The Centers for Disease Control and Prevention on Tuesday recommended the use of Novavax Inc.’s Covid-19 vaccine, the final hurdle before the shot is made widely available in the U.S.
Now Novavax’s long-delayed vaccine will be available to adults 18 years and older who hadn’t been vaccinated previously, offered at no charge at pharmacies and through state and local government vaccine programs.